Dulaglutide is a medicine for type 2 diabetes that also helps lower the chance of heart attack and stroke in some people with diabetes. It is given as a shot under the skin once a week. It works by helping the body release insulin when blood sugar is high and by making you feel full longer.
Every report comes from a Lived member, sent anonymously.
Have you tried Trulicity (Dulaglutide) for Type 2 Diabetes?
Dulaglutide, sold as Trulicity, is a prescription medicine for type 2 diabetes that is injected once a week. Used alongside diet and physical activity, it lowers blood sugar in adults and in children 10 years and older. In adults with type 2 diabetes who already have heart or blood vessel disease, or who have several risk factors for it, Trulicity is also approved to lower the risk of heart attack, stroke and death from cardiovascular causes. That makes it a common choice when protecting the heart is part of the reason for treatment, not only bringing blood sugar down. Dulaglutide belongs to the same family of medicines as semaglutide (Ozempic), called GLP-1 (glucagon-like peptide-1) receptor agonists. It is often added to metformin or other diabetes medicines and can be used together with insulin. Trulicity is not approved as a weight-loss medicine.
After a meal, the gut releases GLP-1, a hormone that signals the pancreas to make insulin. Dulaglutide is a long-acting, lab-made version of this hormone. It activates the same GLP-1 receptors, so the pancreas releases more insulin when blood sugar is high and less glucagon, a hormone that prompts the liver to release stored sugar. Because the extra insulin depends on blood sugar being raised, the main risk of low blood sugar comes from combining dulaglutide with other medicines that lower it regardless of the level. Dulaglutide also slows how quickly the stomach empties. That blunts the rise in blood sugar after meals and leaves many people feeling full sooner, which is why appetite often drops. The molecule is built to last: it takes about five days for the body to clear half of a dose, so one injection covers a whole week.
Trulicity comes in single-dose pens, each holding one week's dose. It is injected under the skin of the abdomen, thigh or upper arm once a week, on the same day each week, at any time of day and with or without food. Move to a different spot each week. A clinician or pharmacist should show you how to use the pen before the first dose. Treatment starts at 0.75 mg a week. The low start mainly gives the stomach time to adjust. After at least four weeks the prescriber may raise the dose, and adults can step up gradually to as much as 4.5 mg a week if more blood sugar lowering is needed. For children 10 and older the highest dose is 1.5 mg. If you miss a dose and at least 3 days (72 hours) remain before the next one, take it as soon as you can. If fewer than 3 days remain, skip it and take the next dose on the usual day. Do not take two doses within 3 days of each other. You can switch your injection day as long as the last dose was at least 3 days earlier. Keep pens in the refrigerator and do not freeze them; a pen that has frozen should not be used. If needed, a pen can stay at room temperature, no warmer than 86°F, for a total of up to 14 days. If you also use insulin, give it as a separate injection and never mix the two in one syringe.
Stomach and bowel effects are the most common: nausea, diarrhea, vomiting, belly pain and a smaller appetite. They are more frequent at higher doses and tend to be most noticeable after starting or increasing the dose, which is why the dose is raised in steps. Vomiting or diarrhea that keeps going can cause dehydration, and in some people dehydration has led to kidney injury. Drink enough fluids, and tell your care team right away if nausea, vomiting or diarrhea does not settle or stomach problems become severe. A few side effects are uncommon but serious. Severe stomach pain that will not go away, sometimes spreading to the back and with or without vomiting, can be a sign of pancreatitis (inflammation of the pancreas). Stop dulaglutide and call your care team right away if this happens. Pain in the upper stomach with fever, yellowing of the skin or eyes, or pale, clay-colored stools can point to a gallbladder problem such as gallstones and also needs a prompt call. Serious allergic reactions are rare. Swelling of the face, lips, tongue or throat, or trouble breathing or swallowing, is an emergency: stop the medicine and call 911.
Trulicity carries a boxed warning, the most prominent caution the U.S. Food and Drug Administration (FDA) requires, about thyroid tumors. In rats, dulaglutide caused thyroid C-cell tumors, including cancers; whether it does this in people is not known. Because of that uncertainty, it is not used by anyone with a personal or family history of medullary thyroid carcinoma (MTC), a rare thyroid cancer, or by people with multiple endocrine neoplasia type 2 (MEN 2), an inherited condition that makes MTC likely. Tell your clinician about a lump or swelling in the neck, hoarseness that persists, trouble swallowing or shortness of breath. Low blood sugar (hypoglycemia) becomes more likely when dulaglutide is combined with insulin or a sulfonylurea, an older type of diabetes pill such as glipizide or glimepiride that pushes the pancreas to release insulin. The prescriber may lower those doses when dulaglutide starts. Shakiness, sweating, a fast heartbeat, hunger, confusion and blurred vision are typical signs, and it helps to know how you will treat a low before one happens. Because dulaglutide slows stomach emptying, food can stay in the stomach longer than expected. Tell the team before any surgery or procedure that uses general anesthesia or deep sedation; in rare cases, stomach contents have entered the lungs. The same slowing can change how quickly some pills are absorbed, which matters most for medicines that need close level checks, such as the blood thinner warfarin. Dulaglutide is not recommended for people with severe gastroparesis, a condition in which the stomach empties very slowly. People with diabetic retinopathy, diabetes-related damage to the back of the eye, should keep up with eye exams, because eye complications were somewhat more common on dulaglutide in that group; report any change in vision. Also tell the care team about any past pancreatitis, and if you are pregnant, planning a pregnancy or breastfeeding. Human pregnancy data are too limited to show whether it is safe, and good blood sugar control in pregnancy is planned with the care team.
The medicine builds up to a steady level after about 2 to 4 weeks of weekly doses. Its effect on blood sugar is judged with the A1C (also called HbA1c), a blood test that reflects average blood sugar over roughly the past three months. In trials, dulaglutide typically lowered A1C by about 0.7 to 1.2 percentage points over six months, depending on the dose and the other medicines people were taking. Many people also lose a little weight; in one six-month trial the average loss was about 3 to 5 pounds. The heart benefit is measured over years, not weeks. In a large trial of adults with type 2 diabetes, about 12 in 100 people taking dulaglutide had a heart attack, stroke or cardiovascular death over roughly five years, compared with about 13 in 100 taking a placebo. Nausea and other stomach effects usually ease as the body adjusts but can return briefly after each dose increase. Follow-up visits check A1C, tolerability and whether a dose change is needed, along with kidney function if vomiting or diarrhea has been a problem and eye exams for people with retinopathy. For most people dulaglutide is a long-term treatment, so any decision to stop is best made with the prescriber, who can plan what will take its place.
Last reviewed • Oct 2026
Educational content, not medical advice.
I've taken Trulicity 1.5 mg for 9 months and it's seems to be lowering my A1C, but not as effectively as Bydureon did. Is anyone else having this issue?